Disease-modifying therapies (DMTs) can prevent acute MS attacks, or relapses, and slow the progression of the disease, thereby preventing physical and cognitive disability. Other drugs, primarily corticosteroids, are used to help control severe symptoms during relapses.
n many chronic conditions, the way the disease will progress over months or years is relatively predictable. That’s not the case with multiple sclerosis (MS); while some people with the disease may be only mildly impacted over years or even decades, others may lose their ability to walk, speak, or swallow over time. And many are affected cognitively, meaning their ability to think, focus, and remember may be impaired, making it difficult to hold down a job.
A drug that treats relapsing-remitting multiple sclerosis – a form of multiple sclerosis that accounts for around 85 percent of people with the condition – has been revealed to reverse some of the damage caused by the disease. This revelation may have implications for future therapeutic strategies for people with the neurological disease.
Growing evidence supports the idea that there is a link between gut bacteria and cognitive function. Previously, Medical News Today has reported on how irritable bowel syndrome may impair communication along the gut-brain axis and raise the risk of anxiety and...
Posted on December 30, 2021 (20) (81) (15) Medically reviewed byAmit M. Shelat, D.O. Article written byBrooke Dulka, Ph.D. Highly effective (HE) disease-modifying treatments (DMTs) can help slow progression of multiple sclerosis (MS) and reduce...
https://youtu.be/v99I56RCdAc MS FATIGUE
This Song Will Remind You To Never, Ever Give Up! (Official Lyric Video NEVER GIVING UP)
By Benjamin Segal, MD, as told to Kara Mayer Robinson We’ve come a long way in treating MS -- it’s been one of the biggest success stories in medicine. Over the last 20 years, there has been a revolution in drugs that change the course of the disease, particularly...
FSD Pharma Unveils Videos Demonstrating Positive Effects of Lucid-MS in Treating Multiple Sclerosis in Pre-Clinical (Mouse Models) Based on more than a decade of research, Lucid-MS is a patented neuroprotective new chemical entity (“NCE”) that affects protein...
